<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care</h2>
    <div class="badge">2025-09-15T16:34:00+00:00</div>
    <ul>
      <li>West Pharmaceutical reported second-quarter 2025 adjusted EPS of $1.84, which beat the Zacks Consensus Estimate by 21.9%.</li>
<li>Medpace Holdings, sporting a Zacks Rank of 1, reported second-quarter 2025 EPS of $3.10, which beat the Zacks Consensus Estimate by 3.3%.</li>
<li>Revenues of $603.3 million outpaced the consensus mark by 11.5%.</li>
<li>Revenues of $682 million surpassed the Zacks Consensus Estimate by 6.3%.</li>
<li>Revenues of $766.5 million surpassed the Zacks Consensus Estimate by 5.4%.</li>
<li>Envista reported second-quarter 2025 adjusted EPS of 26 cents, which beat the Zacks Consensus Estimate by 8.3%.</li>
<li>Favorable Industry Prospects for MMSI Per a report by Grand View Research, the global osteoarthritis therapeutics market size was estimated at $9.13 billion in 2024 and is projected to reach $13.57 billion by 2030, regis</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=MMSI%20Stock%20Falls%20Despite%20CE%20Mark%20Win%20for%20Embosphere%20in%20Knee%20OA%20Care%0A%E2%80%A2%20West%20Pharmaceutical%20reported%20second-quarter%202025%20adjusted%20EPS%20of%20%241.84%2C%20which%20beat%20the%20Zacks%20Consensus%20Estimate%20by%2021.9%25.%0A%E2%80%A2%20Medpace%20Holdings%2C%20sporting%20a%20Zacks%20Rank%20of%201%2C%20reported%20second-quarter%202025%20EPS%20of%20%243.10%2C%20which%20beat%20the%20Zacks%20Consensus%20Estimate%20by%203.3%25.%0A%E2%80%A2%20Revenues%20of%20%24603.3%20million%20outpaced%20the%20consensus%20mark%20by%2011.5%25.%0A%E2%80%A2%20Revenues%20of%20%24682%20million%20surpassed%20the%20Zacks%20Consensus%20Estimate%20by%206.3%25.%0A%E2%80%A2%20Revenues%20of%20%24766.5%20million%20surpassed%20the%20Zacks%20Consensus%20Estimate%20by%205.4%25.%0A%E2%80%A2%20Envista%20reported%20second-quarter%202025%20adjusted%20EPS%20of%2026%20cents%2C%20which%20beat%20the%20Zacks%20Consensus%20Estimate%20by%208.3%25.%0A%E2%80%A2%20Favorable%20Industry%20Prospects%20for%20MMSI%20Per%20a%20report%20by%20Grand%20View%20Research%2C%20the%20global%20osteoarthritis%20therapeutics%20market%20size%20was%20estimated%20at%20%249.13%20billion%20in%202024%20and%20is%20projected%20to%20reach%20%2413.57%20billion%20by%202030%2C%20regis&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fmmsi-stock-falls-despite-ce-mark-win-for-embosphere-in-knee-oa-care%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/mmsi-stock-falls-despite-ce-163400406.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>